- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.10.24 | Darzalex subcutaneous regimen approved by European Commission | ||
| 23.10.24 | Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug | ||
| 22.10.24 | Valneva Scotland announces year-long support for local cancer charity Team Jak | ||
| 21.10.24 | NICE recommends Santen's Roclanda to treat glaucoma and ocular hypertension | ||
| 21.10.24 | Learna and University of Wolverhampton launch flexible healthcare courses | ||
| 17.10.24 | New £4.5m initiative to address UK medicines manufacturing skills shortage | ||
| 17.10.24 | Vivan renews five-year lease at UK biotech hub White City Place | ||
| 16.10.24 | HBC Immunology shares promising results for prostate cancer co-therapy | ||
| 15.10.24 | Celltrion unveils promising dose escalation results for subcutaneous infliximab | ||
| 15.10.24 | Alleo and Ubiquigent unite to accelerate drug discovery | ||
| 14.10.24 | Lundbeck to acquire Longboard Pharmaceuticals in strategic deal | ||
| 14.10.24 | Transgene's cancer vaccine trial shows mixed results | ||
| 10.10.24 | Heart patient goes home hours after live-streamed valve replacement | ||
| 10.10.24 | Johnson & Johnson myeloma drug recommended for NHS use | ||
| 09.10.24 | Purespring Therapeutics secures £80 million in Series B funding | ||
| 09.10.24 | Sanofi launches high-dose flu vaccine in the UK | ||
| 08.10.24 | Kyowa Kirin announces positive interim data for lymphoma treatment | ||
| 08.10.24 | Astellas and AviadoBio announce exclusive gene therapy deal | ||
| 07.10.24 | FluoGuide submits clinical trial application for head and neck cancer treatment | ||
| 07.10.24 | Scottish patients first in UK to access new lung cancer treatment | ||
| 03.10.24 | IRLAB's new drug shows promise in treating apathy in Parkinson's patients | ||
| 03.10.24 | ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
